Skip to content
MedsAcross

Medicine

Cefprozil 500 mg tablet

Cefprozil · Oral
Available on requestPrescription onlyUS FDAGeneric name

Cefprozil 500 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…

Key facts

Active ingredient (INN)
Cefprozil
Brand
Sold under the generic name
Strength
500 mg
Dosage form
Tablet
Route
Oral
Packs
50 tablets, 100 tablets, 500 tablets and 8 more
Manufacturers
Aurobindo PharmaIndiaAscend LaboratoriesIndiaLupinIndiaRising Pharma HoldingsA-S Medication SolutionsNorthStar RxTeva Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 December 2005
Identifiers
RxCUI 197452, 197453DailyMed set ID 6133611e-19c1-4df2-8c23-8573aaf63020, af24a86f-8072-49a6-94ec-2f17fe81812b, 14527f4a-ce99-449d-a5a5-9edd7fb28dee +4NDC 16714-399, 57237-037, 68180-404 +4Application ANDA065340, ANDA065276, ANDA065208 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
50 tablet, film coated in 1 bottle67877-243-50Ascend LaboratoriesIndia20 January 2025
100 tablet, film coated in 1 bottle65862-069-01Aurobindo PharmaIndia24 May 2007
500 tablet, film coated in 1 bottle65862-069-05Aurobindo PharmaIndia24 May 2007
30 tablet, film coated in 1 bottle65862-069-30Aurobindo PharmaIndia24 May 2007
50 tablet, film coated in 1 bottle65862-069-50Aurobindo PharmaIndia24 May 2007
50 tablet in 1 bottle68180-404-01LupinIndia1 December 2005
100 tablet, film coated in 1 bottle57237-037-01Rising Pharma Holdings24 May 2007
50 tablet, film coated in 1 bottle57237-037-50Rising Pharma Holdings24 May 2007
50 tablet, film coated in 1 bottle0093-1078-53Teva Pharmaceuticals23 December 2005
20 tablet, film coated in 1 bottle50090-1710-0A-S Medication Solutions25 February 2015
50 tablet, film coated in 1 bottle16714-399-01NorthStar Rx24 May 2007

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 23 December 1991Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Cefprozil

Clinical summary

Cefprozil is a cephalosporin antibacterial indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. MedsAcross supplies Cefprozil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Cefprozil

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Cefprozil 500 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.